Cavernous sinus sampling in selected cases of Cushing's disease

Standard diagnostic methods for Cushing's disease include plasma ACTH levels, dexamethasone suppression tests, and CRH stimulation tests. These tools confirm the diagnosis in most cases. However, some patients present ambiguous test results and negative MRI scans, making it difficult to distinguish between pituitary and ectopic sources of ACTH. This diagnostic uncertainty limits treatment planning. Prior research has shown that anatomical imaging alone cannot always locate small pituitary adenomas. The lack of reliable localization methods in these complex cases creates a clinical challenge. No prior work had resolved how to accurately identify the source of ACTH in such ambiguous cases. This gap motivated the evaluation of cavernous sinus sampling as a diagnostic tool. The need for better localization methods is critical in guiding surgical decisions. Current approaches fail to consistently identify the correct side for surgery in all patients.

This study aimed to assess the utility of cavernous sinus sampling in diagnosing and localizing ACTH-secreting pituitary adenomas in complex Cushing's disease cases. The focus was on patients with inconclusive endocrine test results and negative MRI findings. The goal was to determine whether CSS could clarify the source of ACTH secretion and guide surgical planning. The researchers sought to compare the diagnostic accuracy of CSS with existing methods. The motivation was to improve preoperative localization of microadenomas. The study also aimed to evaluate the success rate of CSS in predicting lateralization. The researchers wanted to determine if CSS could help avoid unnecessary pituitary surgery. The specific problem addressed was the inability of standard tests to confirm the diagnosis in these complex cases.

The study included 17 patients with ambiguous endocrine test results and negative MRI scans. Cavernous sinus sampling was performed preoperatively in these patients. The procedure involved measuring ACTH gradients between cavernous and peripheral blood samples. The lateralization of the ACTH gradient was used to predict the side of the adenoma. The results were compared with postoperative outcomes and clinical follow-up. The study also evaluated the success rate of catheterization in the cavernous sinus. Anatomical challenges were noted in one patient where catheterization failed. The procedure was compared with inferior petrosal sinus sampling in terms of diagnostic accuracy.

Of the 17 patients, 12 had the classical trias confirmed after repeating endocrine tests. A central-peripheral ACTH gradient was detected in these patients using CSS. In ten of the eleven successfully sampled cases, the lateralization of the adenoma was correctly predicted. In one case with a stalk tumor, a right-sided gradient was observed. One patient had failed catheterization due to anatomical reasons. Eleven patients underwent successful transnasal adenomectomy based on CSS results. Two patients were found to have no active Cushing's syndrome. In three cases, ectopic Cushing's syndrome was suspected based on CSS findings. These patients did not undergo pituitary surgery. The diagnostic accuracy of CSS was found to be higher than inferior petrosal sinus sampling.

The study suggests that cavernous sinus sampling can be a useful diagnostic tool in complex Cushing's disease cases. The authors propose that CSS provides reliable lateralization of ACTH-secreting microadenomas. The results suggest that CSS may improve preoperative localization accuracy. The authors suggest that CSS is more accurate than inferior petrosal sinus sampling in these cases. The study suggests that CSS can help avoid unnecessary surgery in some patients. The findings suggest that CSS can confirm the diagnosis in cases with ambiguous test results. The authors propose that CSS should be considered in patients with inconclusive MRI and endocrine tests. The study suggests that CSS can guide surgical decisions in complex Cushing's disease cases.